Assessing the Interpretation of Molecular Test Results in the Diagnosis of Bloodstream Infections
- PMID: 38732329
- PMCID: PMC11083173
- DOI: 10.3390/diagnostics14090915
Assessing the Interpretation of Molecular Test Results in the Diagnosis of Bloodstream Infections
Abstract
A retrospective study at the 4th Military Clinical Hospital in Wroclaw, Poland, assessed PCR testing alongside blood cultures to guide antimicrobial therapy decisions in hospitalized patients, to determine how much time the results of the molecular tests preceded conventional methods. Among 118 patients, Staphylococcus aureus (37%) and Escherichia coli (21%) were the most common bloodstream infection agents. Blood cultures utilized the BacT/ALERT 3D system, and molecular diagnostics were conducted using the FilmArray platform with the BIOFIRE BCID2 panel. Methicillin susceptibility was observed in 66% of S. aureus strains, while 26% of Gram-negative bacilli exhibited an ESBL phenotype. Therapeutic decisions based on molecular test results were often incorrect for S. aureus infections, particularly MSSA (64.5%), but generally accurate for Gram-negative bacilli. The median times from positive blood culture to BCID2 and pathogen identification/susceptibility were 10 h and 52 h, respectively. Molecular diagnostics facilitated faster initiation of appropriate antibiotic therapy, highlighting the need to educate medical staff on proper interpretation. Consulting within an antimicrobial stewardship program (ASP) could enhance the benefits of implementing molecular methods in bloodstream infection diagnostics.
Keywords: antibiotics; antimicrobial stewardship program; bloodstream infections; molecular diagnostic; sepsis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections.Microbiol Spectr. 2023 Feb 14;11(1):e0254722. doi: 10.1128/spectrum.02547-22. Epub 2022 Dec 15. Microbiol Spectr. 2023. PMID: 36519852 Free PMC article.
-
Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies.BMC Infect Dis. 2022 Oct 20;22(1):794. doi: 10.1186/s12879-022-07772-x. BMC Infect Dis. 2022. PMID: 36266641 Free PMC article.
-
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship.Pathology. 2021 Dec;53(7):889-895. doi: 10.1016/j.pathol.2021.02.016. Epub 2021 Jun 11. Pathology. 2021. PMID: 34120744
-
Rapid and Simple Approaches for Diagnosis of Staphylococcus aureus in Bloodstream Infections.Pol J Microbiol. 2022 Dec 9;71(4):481-489. doi: 10.33073/pjm-2022-050. eCollection 2022 Dec 1. Pol J Microbiol. 2022. PMID: 36476633 Free PMC article. Review.
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
References
-
- Fleischmann M.C., Scherag A., Adhikari N.K.J., Hartog C.S., Tsaganos T., Schlattmann P., Angus D.C., Reinhart K., International Forum of Acute Care Trialists Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am. J. Respir. Crit. Care Med. 2016;193:259–272. doi: 10.1164/rccm.201504-0781OC. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources